- Home
- NVX vs IMRX Comparison
NVX vs IMRX Comparison
Compare NVX & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVX
- IMRX
- Stock Information
- Founded
- NVX 2012
- IMRX 2008
- Country
- NVX Australia
- IMRX United States
- Employees
- NVX N/A
- IMRX N/A
- Industry
- NVX Industrial Machinery/Components
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- NVX Miscellaneous
- IMRX Health Care
- Exchange
- NVX Nasdaq
- IMRX Nasdaq
- Market Cap
- NVX 210.3M
- IMRX 232.9M
- IPO Year
- NVX N/A
- IMRX 2021
- Fundamental
- Price
- NVX $1.23
- IMRX $7.86
- Analyst Decision
- NVX
- IMRX Strong Buy
- Analyst Count
- NVX 0
- IMRX 4
- Target Price
- NVX N/A
- IMRX $13.75
- AVG Volume (30 Days)
- NVX 139.6K
- IMRX 1.2M
- Earning Date
- NVX 01-01-0001
- IMRX 11-12-2025
- Dividend Yield
- NVX N/A
- IMRX N/A
- EPS Growth
- NVX N/A
- IMRX N/A
- EPS
- NVX N/A
- IMRX N/A
- Revenue
- NVX $5,931,433.00
- IMRX N/A
- Revenue This Year
- NVX $135.22
- IMRX N/A
- Revenue Next Year
- NVX $1,647.66
- IMRX N/A
- P/E Ratio
- NVX N/A
- IMRX N/A
- Revenue Growth
- NVX N/A
- IMRX N/A
- 52 Week Low
- NVX $0.81
- IMRX $1.10
- 52 Week High
- NVX $2.73
- IMRX $9.37
- Technical
- Relative Strength Index (RSI)
- NVX 43.71
- IMRX 70.79
- Support Level
- NVX $1.25
- IMRX $5.17
- Resistance Level
- NVX $1.34
- IMRX $9.37
- Average True Range (ATR)
- NVX 0.08
- IMRX 0.75
- MACD
- NVX -0.02
- IMRX 0.26
- Stochastic Oscillator
- NVX 9.37
- IMRX 65.05
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.